AVAMYS
AVAMYS
Approved
DIN Number
02298589
Drug Class
Human
Market Date
Oct 22, 2007
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02298589
AIG Number0152271001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R01AD12 FLUTICASONE FUROATE
Product Specifications
Dosage FormSpray, Metered Dose
Route of AdministrationNasal
AHFS Classification52:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
FLUTICASONE FUROATEActive
Strength: 27.5 MCG / ACT
Monograph: FLUTICASONE FUROATE